| Literature DB >> 35284632 |
Elena Cristofori1, Valentina Zeffiro1, Rosaria Alvaro1, Fabio D'Agostino2, Maurizio Zega3, Antonello Cocchieri4.
Abstract
Introduction: Health literacy (HL) can be defined as the individual's ability to understand and process health information. A low level of HL can be viewed as a stronger predictor of a person's health status than age, education level, and race. Although HL is an important determinant of health, it is often underestimated. This systematic review investigates the evidence on HL assessment in hospital settings.Entities:
Keywords: clinical documentation; electronic health records; health knowledge; health literacy; nursing; systematic review
Year: 2022 PMID: 35284632 PMCID: PMC8905211 DOI: 10.1177/23779608221078555
Source DB: PubMed Journal: SAGE Open Nurs ISSN: 2377-9608
Medline Search Strategy.
|
| ||
|---|---|---|
|
|
| |
|
| (“Health Knowledge, Attitudes, Practice"[Mesh] OR “Health Literacy"[Mesh] OR “functional health literacy” OR (numeracy AND “Health Literacy”) OR “health literacy” OR “health literate” OR “medical literacy” OR low literacy[ti] OR illiteracy[ti] OR illiterate [ti] OR health literate[ti] OR “information literacy"[mesh]) |
|
|
| (“Electronic Health Records"[Mesh] OR “Health Records, Personal"[Mesh] OR “Medical Records, Problem-Oriented"[Mesh] OR “Hospital Records"[Mesh] OR “Medical Records"[Mesh] OR “Nursing Records"[Mesh] OR “Electronic Health Records” OR “Health Records” OR “Problem Oriented Medical Records” OR “Medical Records” OR “Hospital Records” OR “Nursing Records”) |
|
|
| (“hospitals” [Mesh] OR hospital OR hospitals) |
|
|
|
|
|
|
| ||
|
|
| |
| ((“Health Knowledge, Attitudes, Practice"[Mesh] OR “Health Literacy"[Mesh] OR “functional health literacy” OR (numeracy AND “Health Literacy”) OR “health literacy” OR “health literate” OR “medical literacy” OR low literacy[ti] OR illiteracy[ti] OR illiterate [ti] OR health literate[ti] OR “information literacy"[mesh])) AND ((“Electronic Health Records"[Mesh] OR “Health Records, Personal"[Mesh] OR “Medical Records, Problem-Oriented"[Mesh] OR “Hospital Records"[Mesh] OR “Medical Records"[Mesh] OR “Nursing Records"[Mesh] OR “Electronic Health Records” OR “Health Records” OR “Problem Oriented Medical Records” OR “Medical Records” OR “Hospital Records” OR “Nursing Records”)) AND ((“hospitals” [Mesh] OR hospital OR hospitals))
|
| |
Figure 1.Flowchart of literature searching based on PRISMA guideline.
Characteristics of Included Studies.
| N | Surname/year | Design | Country | Setting | Population size | HL Instrument | Type of documentation (e.g. paper or electronic) | HL Evaluator | Implementation process |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cawthon, C/2014 | Oservational study | Nashwille, Tennesse (US) | Academic teaching hospital | Inpatients
| Brief Health Literacy Screen (BHLS) | Electronic Health Records (EHR) | Nurses | A resource nurse or nurse educators, provided education concerning HL assessment tool to nursing staff. Education and training methods: trainers training, staff and unit board meetings, distance learning, videos, posters or flyers. Pre post implementation survey. |
| 2 | Sand-Jecklin, K/2017 | Descriptive study | Morgantown, Virginia (US) | Academic teaching hospital | Inpatient
| Expanded Brief Health Literacy Screen (EBHLS) | Electronic Health Records (EHR) | Nursing and ancillary services staff caring | A resource nurse or nurse educators, provided education concerning HL assessment tool to nursing staff. Education and training methods: specific training sessions, posters within the hospitalization unit. |
| 3 | Sosland, R/2019 | Retrospective study | Nashwille, Tennesse (US) | Academic teaching hospital | Inpatients
| Brief Health Literacy Screen (BHLS) | Electronic Health Records (EHR) | Nurses | - |
| 4 | Warring, CD/2018 | Descriptive study | Gainesville, Florida (US) | Academic teaching hospital | Inpatients
| Rapid Estimate of Adult Literacy in Medicine - Short Form (REALM-SF) | Electronic Health Records (EHR) | Nurses | A resource nurse or nurse educators, provided education concerning HL assessment tool to nursing staff. 3 months pilot study. |
| 5 | Wright, JP/2018 | Observational study | Nashville, Tennesse (US) | Academic teaching hospital | Inpatients
| Brief Health Literacy Screen (BHLS) | Electronic Health Records (EHR) | Nurses | Institutionally implemented. |
STROBE Quality Appraisal of Included Studies.
|
| Sand-Jecklin et al., 2017 |
|
| Sosland et al., 2019 | Not reported N(%) | Reported N(%) | ||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 1a | Indicate the study's design in the title/abstract | + | 4 (80) | 1 (20) | ||||
| 1b | Provide the abstract an informative and balanced summary of what was done and what was found | + | + | + | + | 1 (20) | 4 (80) | |
|
| ||||||||
| 2 | Explain the scientific background and rationale for the investigation being reported | + | + | + | 2 (40) | 3 (60) | ||
| 3 | State specific objectives, including any prespecified hypotheses | + | + | + | + | + | 0 | 5 (100) |
|
| ||||||||
| 4 | Present key elements of study design early in the paper | + | + | + | 2 (40) | 3 (60) | ||
| 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | + | + | + | + | + | 0 | 5 (100) |
| 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants | + | + | 3 (60) | 2 (40) | |||
| 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. | + | + | + | + | + | 0 | 5 (100) |
| 8 | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. | + | + | + | + | 1 (20) | 4 (80) | |
| 9 | Describe any efforts to address potential sources of bias | + | 4 (80) | 1 (20) | ||||
| 10 | Explain how the study size was arrived at | + | + | + | 2 (40) | 3 (60) | ||
| 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | + | + | + | + | 1(20) | 4 (80) | |
| 12a | Describe all statistical methods, including those used to control for confounding | + | + | + | 2 (40) | 3 (60) | ||
| 12b | Describe any methods used to examine subgroups and interactions | + | + | + | 2 (40) | 3 (60) | ||
| 12c | Explain how missing data were addressed | 5 (100) | 0 | |||||
| 12d | If applicable, describe analytical methods taking account of sampling strategy | 5 (100) | 0 | |||||
| 12e | Describe any sensitivity analyses | 5 (100) | 0 | |||||
|
| ||||||||
| 13a | Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | + | + | 3 (60) | 2 (40) | |||
| 13b | Give reasons for non-participation at each stage | 5 (100) | 0 | |||||
| 13c | Consider use of a flow diagram | 5 (100) | 0 | |||||
| 14a | Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders | + | + | + | + | 1 (20) | 4 (80) | |
| 14b | Indicate number of participants with missing data for each variable of interest | 5 (100) | 0 | |||||
| 15 | Report numbers of outcome events or summary measures | + | + | + | + | + | 0 | 5 (100) |
| 16a | Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g. 95% confidence interval). Make clear which confounders were adjusted for and why they were included | + | + | + | 2 (40) | 3 (60) | ||
| 16b | Report category boundaries when continuous variables were categorized | 5 (100) | 0 | |||||
| 16c | If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | 5 (100) | 0 | |||||
| 17 | Report other analyses done—e.g. analyses of subgroups and interactions, and sensitivity analyses | + | + | + | 2 (40) | 3 (60) | ||
|
| ||||||||
| 18 | Summarise key results with reference to study objectives | + | + | + | + | + | 0 | 5 (100) |
| 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | + | + | + | + | 1 (20) | 4 (80) | |
| 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | + | + | + | + | + | 0 | 5 (100) |
| 21 | Discuss the generalizability (external validity) of the study results | 5 (100) | 0 | |||||
|
| ||||||||
| 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | + | + | + | + | 1 (20) | 4 (80) | |
|
|
|
|
|
|
| |||
| Criteria | Author Initials |
| Made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; | EC, VZ, AC |
| Involved in drafting the manuscript or revising it critically for important intellectual content; | EC, VZ, FD, AC |
| Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; | EC, VZ, RA, FD, MZ, AC |
| Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. | EC, VZ, RA, FD, MZ, AC |